Randomised trial of the clinical and cost-effectiveness of a supraglottic airway device versus intubation in-hospital cardiac arrest

niversity Hospitals Bristol and Weston NHS Foundation Trust0 个研究点目标入组 4,190 人开始时间: 2022年7月29日最近更新: 2024年8月12日

适应症

试验速览

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37519411/ Protocol, design and implementation (added 31/07/2023)

•1. Adult (known or believed to be age =18 years)
•2. In-hospital cardiac arrest, attended by the hospital cardiac arrest team in response to a cardiac arrest call (2222 or equivalent), and including a clinician permitted to undertake tracheal intubation and supraglottic airway placement so that either intervention can be delivered
•3. Undergoing resuscitation and requiring advanced airway management in the opinion of the clinician managing the patient’s airway

•Current exclusion criteria as of 02/08/2024:
•1. Patients who have a cardiac arrest outside hospital and who are transported to the hospital in ongoing cardiac arrest
•2. People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient)
•3. Patients already receiving advanced airway management (including a supraglottic airway device) at the time of eligibility assessment
•4. Patients known to be pregnant
•5. Patients with a functioning tracheostomy
•Previous exclusion criteria:
•1. Patients in the emergency department
•2. People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient)
•3. Patients already receiving advanced airway management (including a supraglottic airway device) at the time of eligibility assessment
•4. Patients known to be pregnant
•5. Patients with a functioning tracheostomy

发起方

niversity Hospitals Bristol and Weston NHS Foundation Trust